nodes	percent_of_prediction	percent_of_DWPC	metapath
Amprenavir—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0702	0.0928	CbGbCtD
Amprenavir—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0702	0.0928	CbGbCtD
Amprenavir—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0634	0.0838	CbGbCtD
Amprenavir—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0584	0.0772	CbGbCtD
Amprenavir—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0584	0.0772	CbGbCtD
Amprenavir—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0534	0.0705	CbGbCtD
Amprenavir—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0534	0.0705	CbGbCtD
Amprenavir—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0476	0.0629	CbGbCtD
Amprenavir—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0448	0.0592	CbGbCtD
Amprenavir—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0442	0.0585	CbGbCtD
Amprenavir—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0303	0.04	CbGbCtD
Amprenavir—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0295	0.039	CbGbCtD
Amprenavir—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0289	0.0381	CbGbCtD
Amprenavir—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0257	0.034	CbGbCtD
Amprenavir—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0252	0.0333	CbGbCtD
Amprenavir—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0238	0.0314	CbGbCtD
Amprenavir—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0151	0.0199	CbGbCtD
Amprenavir—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0143	0.0188	CbGbCtD
Amprenavir—Paraesthesia oral—Arformoterol—chronic obstructive pulmonary disease	0.00374	0.0213	CcSEcCtD
Amprenavir—Paraesthesia oral—Formoterol—chronic obstructive pulmonary disease	0.00374	0.0213	CcSEcCtD
Amprenavir—Buffalo hump—Prednisone—chronic obstructive pulmonary disease	0.00344	0.0196	CcSEcCtD
Amprenavir—Lipohypertrophy—Prednisone—chronic obstructive pulmonary disease	0.00316	0.018	CcSEcCtD
Amprenavir—Gastrointestinal symptom NOS—Salbutamol—chronic obstructive pulmonary disease	0.00282	0.0161	CcSEcCtD
Amprenavir—Rhabdomyolysis—Aminophylline—chronic obstructive pulmonary disease	0.0026	0.0149	CcSEcCtD
Amprenavir—Hypercholesterolaemia—Tiotropium—chronic obstructive pulmonary disease	0.0023	0.0131	CcSEcCtD
Amprenavir—Nephrolithiasis—Formoterol—chronic obstructive pulmonary disease	0.00218	0.0124	CcSEcCtD
Amprenavir—Nephrolithiasis—Arformoterol—chronic obstructive pulmonary disease	0.00218	0.0124	CcSEcCtD
Amprenavir—Depression—Roflumilast—chronic obstructive pulmonary disease	0.00193	0.011	CcSEcCtD
Amprenavir—Hepatobiliary disease—Roflumilast—chronic obstructive pulmonary disease	0.00183	0.0104	CcSEcCtD
Amprenavir—Inflammation—Arformoterol—chronic obstructive pulmonary disease	0.00181	0.0103	CcSEcCtD
Amprenavir—Inflammation—Formoterol—chronic obstructive pulmonary disease	0.00181	0.0103	CcSEcCtD
Amprenavir—Opportunistic infection—Prednisone—chronic obstructive pulmonary disease	0.00171	0.00977	CcSEcCtD
Amprenavir—Inflammation—Salbutamol—chronic obstructive pulmonary disease	0.00171	0.00974	CcSEcCtD
Amprenavir—Connective tissue disorder—Roflumilast—chronic obstructive pulmonary disease	0.00171	0.00972	CcSEcCtD
Amprenavir—Cardiac disorder—Roflumilast—chronic obstructive pulmonary disease	0.00161	0.00918	CcSEcCtD
Amprenavir—Mental disorder—Roflumilast—chronic obstructive pulmonary disease	0.00152	0.00867	CcSEcCtD
Amprenavir—Malnutrition—Roflumilast—chronic obstructive pulmonary disease	0.00151	0.00861	CcSEcCtD
Amprenavir—Sleep disorder—Formoterol—chronic obstructive pulmonary disease	0.00147	0.00839	CcSEcCtD
Amprenavir—Sleep disorder—Arformoterol—chronic obstructive pulmonary disease	0.00147	0.00839	CcSEcCtD
Amprenavir—Sleep disorder—Montelukast—chronic obstructive pulmonary disease	0.00144	0.00821	CcSEcCtD
Amprenavir—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.00142	0.00807	CcSEcCtD
Amprenavir—Diabetes mellitus—Salbutamol—chronic obstructive pulmonary disease	0.00138	0.00788	CcSEcCtD
Amprenavir—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.00138	0.00787	CcSEcCtD
Amprenavir—Hyperglycaemia—Aminophylline—chronic obstructive pulmonary disease	0.0013	0.00744	CcSEcCtD
Amprenavir—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.00129	0.00733	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.00128	0.00728	CcSEcCtD
Amprenavir—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00127	0.00725	CcSEcCtD
Amprenavir—Hyperglycaemia—Tiotropium—chronic obstructive pulmonary disease	0.00123	0.00701	CcSEcCtD
Amprenavir—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00121	0.00689	CcSEcCtD
Amprenavir—Hypertriglyceridaemia—Prednisone—chronic obstructive pulmonary disease	0.0012	0.00685	CcSEcCtD
Amprenavir—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.0012	0.00683	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00112	0.00641	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.00112	0.0064	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.0011	0.00627	CcSEcCtD
Amprenavir—Connective tissue disorder—Tiotropium—chronic obstructive pulmonary disease	0.00107	0.00612	CcSEcCtD
Amprenavir—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00107	0.00611	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00106	0.00607	CcSEcCtD
Amprenavir—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00106	0.00606	CcSEcCtD
Amprenavir—Blood triglycerides increased—Prednisone—chronic obstructive pulmonary disease	0.00105	0.00601	CcSEcCtD
Amprenavir—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00101	0.00575	CcSEcCtD
Amprenavir—Hyperglycaemia—Formoterol—chronic obstructive pulmonary disease	0.000993	0.00566	CcSEcCtD
Amprenavir—Hyperglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.000993	0.00566	CcSEcCtD
Amprenavir—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000975	0.00556	CcSEcCtD
Amprenavir—Acute coronary syndrome—Arformoterol—chronic obstructive pulmonary disease	0.000967	0.00552	CcSEcCtD
Amprenavir—Acute coronary syndrome—Formoterol—chronic obstructive pulmonary disease	0.000967	0.00552	CcSEcCtD
Amprenavir—Myocardial infarction—Formoterol—chronic obstructive pulmonary disease	0.000962	0.00548	CcSEcCtD
Amprenavir—Myocardial infarction—Arformoterol—chronic obstructive pulmonary disease	0.000962	0.00548	CcSEcCtD
Amprenavir—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.000956	0.00545	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.000953	0.00543	CcSEcCtD
Amprenavir—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.00095	0.00542	CcSEcCtD
Amprenavir—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.000944	0.00538	CcSEcCtD
Amprenavir—Hyperglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.000937	0.00534	CcSEcCtD
Amprenavir—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.000909	0.00518	CcSEcCtD
Amprenavir—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000885	0.00504	CcSEcCtD
Amprenavir—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.000868	0.00495	CcSEcCtD
Amprenavir—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.000866	0.00494	CcSEcCtD
Amprenavir—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.000866	0.00494	CcSEcCtD
Amprenavir—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.000848	0.00483	CcSEcCtD
Amprenavir—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000844	0.00481	CcSEcCtD
Amprenavir—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.000818	0.00466	CcSEcCtD
Amprenavir—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.000818	0.00466	CcSEcCtD
Amprenavir—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.000817	0.00466	CcSEcCtD
Amprenavir—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.000816	0.00465	CcSEcCtD
Amprenavir—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000809	0.00461	CcSEcCtD
Amprenavir—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000806	0.0046	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000803	0.00458	CcSEcCtD
Amprenavir—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.000801	0.00457	CcSEcCtD
Amprenavir—Diabetes mellitus—Prednisolone—chronic obstructive pulmonary disease	0.000793	0.00452	CcSEcCtD
Amprenavir—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000784	0.00447	CcSEcCtD
Amprenavir—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000784	0.00447	CcSEcCtD
Amprenavir—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000777	0.00443	CcSEcCtD
Amprenavir—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000777	0.00443	CcSEcCtD
Amprenavir—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000772	0.0044	CcSEcCtD
Amprenavir—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000772	0.0044	CcSEcCtD
Amprenavir—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000772	0.0044	CcSEcCtD
Amprenavir—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000772	0.0044	CcSEcCtD
Amprenavir—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000767	0.00437	CcSEcCtD
Amprenavir—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000767	0.00437	CcSEcCtD
Amprenavir—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00076	0.00434	CcSEcCtD
Amprenavir—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000756	0.00431	CcSEcCtD
Amprenavir—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000753	0.00429	CcSEcCtD
Amprenavir—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000732	0.00418	CcSEcCtD
Amprenavir—Hypercholesterolaemia—Prednisone—chronic obstructive pulmonary disease	0.00073	0.00416	CcSEcCtD
Amprenavir—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000729	0.00415	CcSEcCtD
Amprenavir—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000724	0.00413	CcSEcCtD
Amprenavir—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000718	0.0041	CcSEcCtD
Amprenavir—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000718	0.0041	CcSEcCtD
Amprenavir—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000715	0.00408	CcSEcCtD
Amprenavir—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000713	0.00407	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000707	0.00403	CcSEcCtD
Amprenavir—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000704	0.00401	CcSEcCtD
Amprenavir—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000701	0.00399	CcSEcCtD
Amprenavir—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000701	0.00399	CcSEcCtD
Amprenavir—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000696	0.00397	CcSEcCtD
Amprenavir—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000686	0.00391	CcSEcCtD
Amprenavir—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000678	0.00387	CcSEcCtD
Amprenavir—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000672	0.00383	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000669	0.00382	CcSEcCtD
Amprenavir—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000662	0.00377	CcSEcCtD
Amprenavir—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000653	0.00372	CcSEcCtD
Amprenavir—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000653	0.00372	CcSEcCtD
Amprenavir—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00065	0.00371	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000648	0.0037	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000648	0.0037	CcSEcCtD
Amprenavir—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000645	0.00368	CcSEcCtD
Amprenavir—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000645	0.00368	CcSEcCtD
Amprenavir—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000639	0.00365	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000635	0.00362	CcSEcCtD
Amprenavir—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000634	0.00362	CcSEcCtD
Amprenavir—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000616	0.00351	CcSEcCtD
Amprenavir—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000614	0.0035	CcSEcCtD
Amprenavir—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000614	0.0035	CcSEcCtD
Amprenavir—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000613	0.0035	CcSEcCtD
Amprenavir—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000609	0.00347	CcSEcCtD
Amprenavir—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000608	0.00347	CcSEcCtD
Amprenavir—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000608	0.00347	CcSEcCtD
Amprenavir—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000601	0.00343	CcSEcCtD
Amprenavir—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000595	0.00339	CcSEcCtD
Amprenavir—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000582	0.00332	CcSEcCtD
Amprenavir—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00058	0.0033	CcSEcCtD
Amprenavir—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000576	0.00328	CcSEcCtD
Amprenavir—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000574	0.00327	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00057	0.00325	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00057	0.00325	CcSEcCtD
Amprenavir—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000563	0.00321	CcSEcCtD
Amprenavir—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000563	0.00321	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000558	0.00318	CcSEcCtD
Amprenavir—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00055	0.00314	CcSEcCtD
Amprenavir—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000549	0.00313	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00054	0.00308	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00054	0.00308	CcSEcCtD
Amprenavir—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00054	0.00308	CcSEcCtD
Amprenavir—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00054	0.00308	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000538	0.00307	CcSEcCtD
Amprenavir—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000531	0.00303	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000529	0.00302	CcSEcCtD
Amprenavir—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000529	0.00301	CcSEcCtD
Amprenavir—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000524	0.00299	CcSEcCtD
Amprenavir—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000523	0.00298	CcSEcCtD
Amprenavir—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000521	0.00297	CcSEcCtD
Amprenavir—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000518	0.00296	CcSEcCtD
Amprenavir—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000518	0.00295	CcSEcCtD
Amprenavir—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000515	0.00294	CcSEcCtD
Amprenavir—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000514	0.00293	CcSEcCtD
Amprenavir—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000512	0.00292	CcSEcCtD
Amprenavir—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000512	0.00292	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00051	0.00291	CcSEcCtD
Amprenavir—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000509	0.0029	CcSEcCtD
Amprenavir—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000501	0.00286	CcSEcCtD
Amprenavir—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000495	0.00282	CcSEcCtD
Amprenavir—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000495	0.00282	CcSEcCtD
Amprenavir—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000493	0.00281	CcSEcCtD
Amprenavir—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000489	0.00279	CcSEcCtD
Amprenavir—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000489	0.00279	CcSEcCtD
Amprenavir—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000488	0.00278	CcSEcCtD
Amprenavir—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000486	0.00277	CcSEcCtD
Amprenavir—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000485	0.00276	CcSEcCtD
Amprenavir—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000483	0.00276	CcSEcCtD
Amprenavir—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000467	0.00266	CcSEcCtD
Amprenavir—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000461	0.00263	CcSEcCtD
Amprenavir—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000449	0.00256	CcSEcCtD
Amprenavir—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000449	0.00256	CcSEcCtD
Amprenavir—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000443	0.00252	CcSEcCtD
Amprenavir—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000443	0.00252	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000442	0.00252	CcSEcCtD
Amprenavir—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00044	0.00251	CcSEcCtD
Amprenavir—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000434	0.00247	CcSEcCtD
Amprenavir—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000428	0.00244	CcSEcCtD
Amprenavir—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000428	0.00244	CcSEcCtD
Amprenavir—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000424	0.00242	CcSEcCtD
Amprenavir—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000419	0.00239	CcSEcCtD
Amprenavir—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000418	0.00238	CcSEcCtD
Amprenavir—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000405	0.00231	CcSEcCtD
Amprenavir—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000404	0.00231	CcSEcCtD
Amprenavir—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000398	0.00227	CcSEcCtD
Amprenavir—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000398	0.00227	CcSEcCtD
Amprenavir—Rash—Formoterol—chronic obstructive pulmonary disease	0.000395	0.00225	CcSEcCtD
Amprenavir—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000395	0.00225	CcSEcCtD
Amprenavir—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000394	0.00225	CcSEcCtD
Amprenavir—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000394	0.00225	CcSEcCtD
Amprenavir—Headache—Formoterol—chronic obstructive pulmonary disease	0.000392	0.00224	CcSEcCtD
Amprenavir—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000392	0.00224	CcSEcCtD
Amprenavir—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000391	0.00223	CcSEcCtD
Amprenavir—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00039	0.00222	CcSEcCtD
Amprenavir—Rash—Montelukast—chronic obstructive pulmonary disease	0.000387	0.0022	CcSEcCtD
Amprenavir—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000386	0.0022	CcSEcCtD
Amprenavir—Depression—Prednisone—chronic obstructive pulmonary disease	0.000385	0.0022	CcSEcCtD
Amprenavir—Headache—Montelukast—chronic obstructive pulmonary disease	0.000384	0.00219	CcSEcCtD
Amprenavir—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000381	0.00217	CcSEcCtD
Amprenavir—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000379	0.00216	CcSEcCtD
Amprenavir—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000379	0.00216	CcSEcCtD
Amprenavir—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000376	0.00214	CcSEcCtD
Amprenavir—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000373	0.00212	CcSEcCtD
Amprenavir—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000372	0.00212	CcSEcCtD
Amprenavir—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000372	0.00212	CcSEcCtD
Amprenavir—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000372	0.00212	CcSEcCtD
Amprenavir—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00037	0.00211	CcSEcCtD
Amprenavir—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000364	0.00208	CcSEcCtD
Amprenavir—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000351	0.002	CcSEcCtD
Amprenavir—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000349	0.00199	CcSEcCtD
Amprenavir—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000341	0.00194	CcSEcCtD
Amprenavir—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000304	0.00174	CcSEcCtD
Amprenavir—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000304	0.00173	CcSEcCtD
Amprenavir—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000302	0.00172	CcSEcCtD
Amprenavir—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000276	0.00157	CcSEcCtD
Amprenavir—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000257	0.00146	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000255	0.00145	CcSEcCtD
Amprenavir—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000254	0.00145	CcSEcCtD
Amprenavir—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000242	0.00138	CcSEcCtD
Amprenavir—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000239	0.00136	CcSEcCtD
Amprenavir—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000235	0.00134	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000224	0.00128	CcSEcCtD
Amprenavir—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000221	0.00126	CcSEcCtD
Amprenavir—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000214	0.00122	CcSEcCtD
Amprenavir—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000214	0.00122	CcSEcCtD
Amprenavir—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000214	0.00122	CcSEcCtD
Amprenavir—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000212	0.00121	CcSEcCtD
Amprenavir—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000212	0.00121	CcSEcCtD
Amprenavir—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000201	0.00115	CcSEcCtD
Amprenavir—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000201	0.00115	CcSEcCtD
Amprenavir—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000195	0.00111	CcSEcCtD
Amprenavir—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000177	0.00101	CcSEcCtD
Amprenavir—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000174	0.000994	CcSEcCtD
Amprenavir—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000169	0.000961	CcSEcCtD
Amprenavir—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000157	0.000893	CcSEcCtD
Amprenavir—Rash—Prednisone—chronic obstructive pulmonary disease	0.000155	0.000885	CcSEcCtD
Amprenavir—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000155	0.000885	CcSEcCtD
Amprenavir—Headache—Prednisone—chronic obstructive pulmonary disease	0.000154	0.00088	CcSEcCtD
Amprenavir—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000834	CcSEcCtD
Amprenavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000141	0.00207	CbGpPWpGaD
Amprenavir—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	0.00014	0.00206	CbGpPWpGaD
Amprenavir—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000139	0.00204	CbGpPWpGaD
Amprenavir—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000138	0.00203	CbGpPWpGaD
Amprenavir—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000136	0.002	CbGpPWpGaD
Amprenavir—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000134	0.00197	CbGpPWpGaD
Amprenavir—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000134	0.00197	CbGpPWpGaD
Amprenavir—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000133	0.00196	CbGpPWpGaD
Amprenavir—CYP2B6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000133	0.00196	CbGpPWpGaD
Amprenavir—CYP2B6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000131	0.00193	CbGpPWpGaD
Amprenavir—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.00013	0.00192	CbGpPWpGaD
Amprenavir—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000128	0.00189	CbGpPWpGaD
Amprenavir—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000127	0.00186	CbGpPWpGaD
Amprenavir—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000126	0.00186	CbGpPWpGaD
Amprenavir—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000126	0.00185	CbGpPWpGaD
Amprenavir—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000124	0.00183	CbGpPWpGaD
Amprenavir—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000121	0.00178	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000121	0.00178	CbGpPWpGaD
Amprenavir—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00012	0.00176	CbGpPWpGaD
Amprenavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000114	0.00168	CbGpPWpGaD
Amprenavir—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000113	0.00166	CbGpPWpGaD
Amprenavir—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000111	0.00164	CbGpPWpGaD
Amprenavir—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000111	0.00164	CbGpPWpGaD
Amprenavir—CYP2B6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000111	0.00163	CbGpPWpGaD
Amprenavir—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00011	0.00163	CbGpPWpGaD
Amprenavir—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00011	0.00162	CbGpPWpGaD
Amprenavir—CYP2B6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.00011	0.00161	CbGpPWpGaD
Amprenavir—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000109	0.00161	CbGpPWpGaD
Amprenavir—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000109	0.0016	CbGpPWpGaD
Amprenavir—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000107	0.00158	CbGpPWpGaD
Amprenavir—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000105	0.00154	CbGpPWpGaD
Amprenavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000102	0.0015	CbGpPWpGaD
Amprenavir—CYP2B6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000102	0.0015	CbGpPWpGaD
Amprenavir—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000101	0.00148	CbGpPWpGaD
Amprenavir—CYP2B6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000101	0.00148	CbGpPWpGaD
Amprenavir—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000101	0.00148	CbGpPWpGaD
Amprenavir—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	9.98e-05	0.00147	CbGpPWpGaD
Amprenavir—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.93e-05	0.00146	CbGpPWpGaD
Amprenavir—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	9.85e-05	0.00145	CbGpPWpGaD
Amprenavir—CYP2B6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.68e-05	0.00142	CbGpPWpGaD
Amprenavir—CYP2B6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.55e-05	0.0014	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	9.54e-05	0.0014	CbGpPWpGaD
Amprenavir—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.47e-05	0.00139	CbGpPWpGaD
Amprenavir—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	9.41e-05	0.00138	CbGpPWpGaD
Amprenavir—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.34e-05	0.00137	CbGpPWpGaD
Amprenavir—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	9.28e-05	0.00137	CbGpPWpGaD
Amprenavir—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.26e-05	0.00136	CbGpPWpGaD
Amprenavir—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.18e-05	0.00135	CbGpPWpGaD
Amprenavir—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.14e-05	0.00134	CbGpPWpGaD
Amprenavir—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.06e-05	0.00133	CbGpPWpGaD
Amprenavir—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.65e-05	0.00127	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	8.61e-05	0.00127	CbGpPWpGaD
Amprenavir—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	8.53e-05	0.00125	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	8.52e-05	0.00125	CbGpPWpGaD
Amprenavir—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.4e-05	0.00124	CbGpPWpGaD
Amprenavir—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.28e-05	0.00122	CbGpPWpGaD
Amprenavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.28e-05	0.00122	CbGpPWpGaD
Amprenavir—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	8.2e-05	0.00121	CbGpPWpGaD
Amprenavir—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	8.09e-05	0.00119	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8e-05	0.00118	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	7.93e-05	0.00117	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—APIP—chronic obstructive pulmonary disease	7.79e-05	0.00115	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—GC—chronic obstructive pulmonary disease	7.78e-05	0.00114	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.77e-05	0.00114	CbGpPWpGaD
Amprenavir—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.73e-05	0.00114	CbGpPWpGaD
Amprenavir—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.72e-05	0.00114	CbGpPWpGaD
Amprenavir—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	7.68e-05	0.00113	CbGpPWpGaD
Amprenavir—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.66e-05	0.00113	CbGpPWpGaD
Amprenavir—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.62e-05	0.00112	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	7.61e-05	0.00112	CbGpPWpGaD
Amprenavir—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.61e-05	0.00112	CbGpPWpGaD
Amprenavir—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.55e-05	0.00111	CbGpPWpGaD
Amprenavir—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	7.36e-05	0.00108	CbGpPWpGaD
Amprenavir—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.32e-05	0.00108	CbGpPWpGaD
Amprenavir—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.29e-05	0.00107	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.24e-05	0.00106	CbGpPWpGaD
Amprenavir—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.22e-05	0.00106	CbGpPWpGaD
Amprenavir—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.2e-05	0.00106	CbGpPWpGaD
Amprenavir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	7.2e-05	0.00106	CbGpPWpGaD
Amprenavir—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.1e-05	0.00104	CbGpPWpGaD
Amprenavir—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.04e-05	0.00104	CbGpPWpGaD
Amprenavir—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7e-05	0.00103	CbGpPWpGaD
Amprenavir—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.94e-05	0.00102	CbGpPWpGaD
Amprenavir—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.73e-05	0.00099	CbGpPWpGaD
Amprenavir—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.67e-05	0.000981	CbGpPWpGaD
Amprenavir—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.64e-05	0.000976	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	6.6e-05	0.00097	CbGpPWpGaD
Amprenavir—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.58e-05	0.000968	CbGpPWpGaD
Amprenavir—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	6.23e-05	0.000917	CbGpPWpGaD
Amprenavir—ABCC1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.21e-05	0.000913	CbGpPWpGaD
Amprenavir—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.06e-05	0.000891	CbGpPWpGaD
Amprenavir—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.97e-05	0.000878	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	5.89e-05	0.000866	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.76e-05	0.000848	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	5.75e-05	0.000845	CbGpPWpGaD
Amprenavir—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	5.72e-05	0.000842	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	5.41e-05	0.000796	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	5.37e-05	0.000789	CbGpPWpGaD
Amprenavir—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	5.34e-05	0.000786	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.16e-05	0.000759	CbGpPWpGaD
Amprenavir—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.05e-05	0.000743	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.04e-05	0.000742	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	5.02e-05	0.000738	CbGpPWpGaD
Amprenavir—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.98e-05	0.000733	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	4.91e-05	0.000722	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.7e-05	0.000692	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.67e-05	0.000686	CbGpPWpGaD
Amprenavir—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.64e-05	0.000683	CbGpPWpGaD
Amprenavir—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.58e-05	0.000673	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.56e-05	0.000671	CbGpPWpGaD
Amprenavir—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.4e-05	0.000647	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.37e-05	0.000643	CbGpPWpGaD
Amprenavir—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.34e-05	0.000638	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.33e-05	0.000637	CbGpPWpGaD
Amprenavir—ABCC1—Disease—HDAC2—chronic obstructive pulmonary disease	4.27e-05	0.000628	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.25e-05	0.000625	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	4.25e-05	0.000625	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—GCLC—chronic obstructive pulmonary disease	4.2e-05	0.000618	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.2e-05	0.000617	CbGpPWpGaD
Amprenavir—ABCC1—Disease—KL—chronic obstructive pulmonary disease	3.97e-05	0.000583	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.95e-05	0.000581	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.92e-05	0.000576	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.9e-05	0.000574	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.87e-05	0.000569	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.84e-05	0.000564	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.83e-05	0.000563	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.81e-05	0.00056	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	3.79e-05	0.000558	CbGpPWpGaD
Amprenavir—ABCC1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.73e-05	0.000548	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	3.7e-05	0.000545	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.59e-05	0.000528	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.56e-05	0.000523	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.54e-05	0.000521	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.53e-05	0.00052	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.53e-05	0.000519	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.53e-05	0.000519	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	3.49e-05	0.000513	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	3.46e-05	0.000509	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.44e-05	0.000506	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.24e-05	0.000477	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.22e-05	0.000473	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.15e-05	0.000463	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	3.08e-05	0.000453	CbGpPWpGaD
Amprenavir—ABCC1—Disease—ERBB3—chronic obstructive pulmonary disease	2.97e-05	0.000437	CbGpPWpGaD
Amprenavir—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.95e-05	0.000434	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.95e-05	0.000433	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.91e-05	0.000427	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.82e-05	0.000415	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.81e-05	0.000413	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.77e-05	0.000407	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.74e-05	0.000403	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	2.71e-05	0.000399	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.71e-05	0.000398	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.68e-05	0.000394	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	2.65e-05	0.00039	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	2.64e-05	0.000388	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.57e-05	0.000378	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.56e-05	0.000377	CbGpPWpGaD
Amprenavir—ABCC1—Disease—NOS2—chronic obstructive pulmonary disease	2.48e-05	0.000365	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	2.47e-05	0.000364	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	2.42e-05	0.000356	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.35e-05	0.000345	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.32e-05	0.000342	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.32e-05	0.000341	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	2.3e-05	0.000338	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.28e-05	0.000336	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.28e-05	0.000335	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.23e-05	0.000328	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.14e-05	0.000315	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.12e-05	0.000312	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	2.09e-05	0.000308	CbGpPWpGaD
Amprenavir—ABCC1—Disease—SERPINE1—chronic obstructive pulmonary disease	2.09e-05	0.000307	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.07e-05	0.000305	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	2.05e-05	0.000301	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.02e-05	0.000298	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	2e-05	0.000294	CbGpPWpGaD
Amprenavir—ABCC1—Disease—NOS3—chronic obstructive pulmonary disease	1.99e-05	0.000293	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.93e-05	0.000284	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.91e-05	0.000281	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.91e-05	0.00028	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.9e-05	0.00028	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.89e-05	0.000278	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.88e-05	0.000277	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.87e-05	0.000276	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.87e-05	0.000275	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.87e-05	0.000275	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.86e-05	0.000273	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.83e-05	0.00027	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.82e-05	0.000268	CbGpPWpGaD
Amprenavir—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.77e-05	0.000261	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.75e-05	0.000257	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—ALB—chronic obstructive pulmonary disease	1.75e-05	0.000257	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.74e-05	0.000256	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.72e-05	0.000253	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.72e-05	0.000253	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.71e-05	0.000251	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.7e-05	0.000251	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.68e-05	0.000247	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.67e-05	0.000246	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.66e-05	0.000244	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.62e-05	0.000238	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.61e-05	0.000237	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.59e-05	0.000233	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.58e-05	0.000233	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.57e-05	0.000231	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.48e-05	0.000218	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.44e-05	0.000211	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.42e-05	0.000208	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.4e-05	0.000206	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.4e-05	0.000206	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.38e-05	0.000203	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.32e-05	0.000194	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.32e-05	0.000194	CbGpPWpGaD
Amprenavir—ABCC1—Disease—TGFB1—chronic obstructive pulmonary disease	1.32e-05	0.000194	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.31e-05	0.000193	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.3e-05	0.000192	CbGpPWpGaD
Amprenavir—ABCC1—Disease—EGFR—chronic obstructive pulmonary disease	1.29e-05	0.00019	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.29e-05	0.00019	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.29e-05	0.000189	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.25e-05	0.000184	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.25e-05	0.000183	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.23e-05	0.000181	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.22e-05	0.00018	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.21e-05	0.000179	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.2e-05	0.000177	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.15e-05	0.000169	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.14e-05	0.000168	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	1.13e-05	0.000166	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.12e-05	0.000165	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	1.1e-05	0.000162	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.08e-05	0.000158	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	1.05e-05	0.000155	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.04e-05	0.000152	CbGpPWpGaD
Amprenavir—ABCC1—Disease—IL6—chronic obstructive pulmonary disease	9.93e-06	0.000146	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	9.53e-06	0.00014	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	9.12e-06	0.000134	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.64e-06	0.000127	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.52e-06	0.000125	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	8.51e-06	0.000125	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	8.3e-06	0.000122	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	8.14e-06	0.00012	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	7.94e-06	0.000117	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.94e-06	0.000117	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	7.82e-06	0.000115	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	7.76e-06	0.000114	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.53e-06	0.000111	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	7.48e-06	0.00011	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	7.42e-06	0.000109	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	5.12e-06	7.52e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	4.89e-06	7.2e-05	CbGpPWpGaD
